Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

The Cancer Genome Atlas Research Network

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The Cancer Genome Atlas (TCGA) has catalyzed systematic characterization of diverse genomic alterations underlying human cancers. At this historic junction marking the completion of genomic characterization of over 11,000 tumors from 33 cancer types, we present our current understanding of the molecular processes governing oncogenesis. We illustrate our insights into cancer through synthesis of the findings of the TCGA PanCancer Atlas project on three facets of oncogenesis: (1) somatic driver mutations, germline pathogenic variants, and their interactions in the tumor; (2) the influence of the tumor genome and epigenome on transcriptome and proteome; and (3) the relationship between tumor and the microenvironment, including implications for drugs targeting driver events and immunotherapies. These results will anchor future characterization of rare and common tumor types, primary and relapsed tumors, and cancers across ancestry groups and will guide the deployment of clinical genomic sequencing. A synthesized view on oncogenic processes based on PanCancer Atlas analyses highlights the complex impact of genome alterations on the signaling and multi-omic profiles of human cancers as well as their influence on tumor microenvironment.

Original languageEnglish (US)
Pages (from-to)305-320.e10
JournalCell
Volume173
Issue number2
DOIs
StatePublished - Apr 5 2018

Fingerprint

Genomics
Tumors
Genes
Neoplasms
Atlases
Genome
Tumor Microenvironment
Proteome
Anchors
Carcinogenesis
Germ-Line Mutation
Drug Delivery Systems
Transcriptome
Immunotherapy

Keywords

  • cancer
  • cancer genomics
  • omics
  • oncogenic process
  • TCGA

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. / The Cancer Genome Atlas Research Network.

In: Cell, Vol. 173, No. 2, 05.04.2018, p. 305-320.e10.

Research output: Contribution to journalArticle

The Cancer Genome Atlas Research Network 2018, 'Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics', Cell, vol. 173, no. 2, pp. 305-320.e10. https://doi.org/10.1016/j.cell.2018.03.033
The Cancer Genome Atlas Research Network. / Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. In: Cell. 2018 ; Vol. 173, No. 2. pp. 305-320.e10.
@article{ea7f9e057dbd4d95a61e4a476fc94520,
title = "Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics",
abstract = "The Cancer Genome Atlas (TCGA) has catalyzed systematic characterization of diverse genomic alterations underlying human cancers. At this historic junction marking the completion of genomic characterization of over 11,000 tumors from 33 cancer types, we present our current understanding of the molecular processes governing oncogenesis. We illustrate our insights into cancer through synthesis of the findings of the TCGA PanCancer Atlas project on three facets of oncogenesis: (1) somatic driver mutations, germline pathogenic variants, and their interactions in the tumor; (2) the influence of the tumor genome and epigenome on transcriptome and proteome; and (3) the relationship between tumor and the microenvironment, including implications for drugs targeting driver events and immunotherapies. These results will anchor future characterization of rare and common tumor types, primary and relapsed tumors, and cancers across ancestry groups and will guide the deployment of clinical genomic sequencing. A synthesized view on oncogenic processes based on PanCancer Atlas analyses highlights the complex impact of genome alterations on the signaling and multi-omic profiles of human cancers as well as their influence on tumor microenvironment.",
keywords = "cancer, cancer genomics, omics, oncogenic process, TCGA",
author = "{The Cancer Genome Atlas Research Network} and Li Ding and Bailey, {Matthew H.} and Eduard Porta-Pardo and Vesteinn Thorsson and Antonio Colaprico and Denis Bertrand and Gibbs, {David L.} and Amila Weerasinghe and Huang, {Kuan lin} and Collin Tokheim and Isidro Cort{\'e}s-Ciriano and Reyka Jayasinghe and Feng Chen and Lihua Yu and Sam Sun and Catharina Olsen and Jaegil Kim and Taylor, {Alison M.} and Cherniack, {Andrew D.} and Rehan Akbani and Chayaporn Suphavilai and Niranjan Nagarajan and Stuart, {Joshua M.} and Gordon Mills and Wyczalkowski, {Matthew A.} and Vincent, {Benjamin G.} and Hutter, {Carolyn M.} and Zenklusen, {Jean Claude} and Hoadley, {Katherine A.} and Wendl, {Michael C.} and llya Shmulevich and Lazar, {Alexander J.} and Wheeler, {David A.} and Gad Getz and Caesar-Johnson, {Samantha J.} and Demchok, {John A.} and Ina Felau and Melpomeni Kasapi and Ferguson, {Martin L.} and Sofia, {Heidi J.} and Roy Tarnuzzer and Zhining Wang and Liming Yang and Zhang, {Jiashan (Julia)} and Sudha Chudamani and Jia Liu and Laxmi Lolla and Rashi Naresh and Paul Spellman and George Thomas",
year = "2018",
month = "4",
day = "5",
doi = "10.1016/j.cell.2018.03.033",
language = "English (US)",
volume = "173",
pages = "305--320.e10",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

AU - The Cancer Genome Atlas Research Network

AU - Ding, Li

AU - Bailey, Matthew H.

AU - Porta-Pardo, Eduard

AU - Thorsson, Vesteinn

AU - Colaprico, Antonio

AU - Bertrand, Denis

AU - Gibbs, David L.

AU - Weerasinghe, Amila

AU - Huang, Kuan lin

AU - Tokheim, Collin

AU - Cortés-Ciriano, Isidro

AU - Jayasinghe, Reyka

AU - Chen, Feng

AU - Yu, Lihua

AU - Sun, Sam

AU - Olsen, Catharina

AU - Kim, Jaegil

AU - Taylor, Alison M.

AU - Cherniack, Andrew D.

AU - Akbani, Rehan

AU - Suphavilai, Chayaporn

AU - Nagarajan, Niranjan

AU - Stuart, Joshua M.

AU - Mills, Gordon

AU - Wyczalkowski, Matthew A.

AU - Vincent, Benjamin G.

AU - Hutter, Carolyn M.

AU - Zenklusen, Jean Claude

AU - Hoadley, Katherine A.

AU - Wendl, Michael C.

AU - Shmulevich, llya

AU - Lazar, Alexander J.

AU - Wheeler, David A.

AU - Getz, Gad

AU - Caesar-Johnson, Samantha J.

AU - Demchok, John A.

AU - Felau, Ina

AU - Kasapi, Melpomeni

AU - Ferguson, Martin L.

AU - Sofia, Heidi J.

AU - Tarnuzzer, Roy

AU - Wang, Zhining

AU - Yang, Liming

AU - Zhang, Jiashan (Julia)

AU - Chudamani, Sudha

AU - Liu, Jia

AU - Lolla, Laxmi

AU - Naresh, Rashi

AU - Spellman, Paul

AU - Thomas, George

PY - 2018/4/5

Y1 - 2018/4/5

N2 - The Cancer Genome Atlas (TCGA) has catalyzed systematic characterization of diverse genomic alterations underlying human cancers. At this historic junction marking the completion of genomic characterization of over 11,000 tumors from 33 cancer types, we present our current understanding of the molecular processes governing oncogenesis. We illustrate our insights into cancer through synthesis of the findings of the TCGA PanCancer Atlas project on three facets of oncogenesis: (1) somatic driver mutations, germline pathogenic variants, and their interactions in the tumor; (2) the influence of the tumor genome and epigenome on transcriptome and proteome; and (3) the relationship between tumor and the microenvironment, including implications for drugs targeting driver events and immunotherapies. These results will anchor future characterization of rare and common tumor types, primary and relapsed tumors, and cancers across ancestry groups and will guide the deployment of clinical genomic sequencing. A synthesized view on oncogenic processes based on PanCancer Atlas analyses highlights the complex impact of genome alterations on the signaling and multi-omic profiles of human cancers as well as their influence on tumor microenvironment.

AB - The Cancer Genome Atlas (TCGA) has catalyzed systematic characterization of diverse genomic alterations underlying human cancers. At this historic junction marking the completion of genomic characterization of over 11,000 tumors from 33 cancer types, we present our current understanding of the molecular processes governing oncogenesis. We illustrate our insights into cancer through synthesis of the findings of the TCGA PanCancer Atlas project on three facets of oncogenesis: (1) somatic driver mutations, germline pathogenic variants, and their interactions in the tumor; (2) the influence of the tumor genome and epigenome on transcriptome and proteome; and (3) the relationship between tumor and the microenvironment, including implications for drugs targeting driver events and immunotherapies. These results will anchor future characterization of rare and common tumor types, primary and relapsed tumors, and cancers across ancestry groups and will guide the deployment of clinical genomic sequencing. A synthesized view on oncogenic processes based on PanCancer Atlas analyses highlights the complex impact of genome alterations on the signaling and multi-omic profiles of human cancers as well as their influence on tumor microenvironment.

KW - cancer

KW - cancer genomics

KW - omics

KW - oncogenic process

KW - TCGA

UR - http://www.scopus.com/inward/record.url?scp=85044744316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044744316&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2018.03.033

DO - 10.1016/j.cell.2018.03.033

M3 - Article

VL - 173

SP - 305-320.e10

JO - Cell

JF - Cell

SN - 0092-8674

IS - 2

ER -